Advance and challenge in research on meningococcal group B vaccines / 药物评价研究
Drug Evaluation Research
;
(6): 1163-1167, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-660912
ABSTRACT
It is generally accepted that vaccinations are one of the most effective tool for control of infectious diseases.In recent years,the research on meningococcal group B vaccines has made progress extensively.A new meningococcal group B vaccine,developed by the reverse vaccinology technology,has been approved by the European Medicines Agency and the Food and Drag Administration.Although no related products has been approve till now in China,some meningococcal group B vaccines are also developing in domestic companies and research institutes.Therefore,to further understand these vaccines and facilitate the development of meningococcal group B vaccines,this paper reviews advance and challenge in research on meningococcal group B vaccines.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Drug Evaluation Research
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS